IMCR8:00 AMImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanomaPresentation / Abstract • Phase 1ASCO poster presentation Sun, May 31, 2026, 9:00 AM CDTGimmunocore.com
IMCR7:00 AMImmunocore reports first quarter financial results and provides a business updateimmunocore.com
IMCR6:00 PMKIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaPresentation / Abstract • Phase 3immunocore.com